Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EGFR testing in lung cancer is ready for prime time.

× No keyword cloud information.

77 in total

1. PIK3CA mutation in Chinese patients with lung squamous cell carcinoma.

Authors: Jinglin Yu; Hua Bai; Zhijie Wang; Zhigang Wei; Xiaosheng Ding; Jianchun Duan; Lu Yang; Meina Wu; Yuyan Wang; Jie Wang
Journal: Chin J Cancer Res Date: 2013-08 Impact factor: 5.087

2. Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer.

Authors: Haiying Cheng; H Dean Hosgood; Lei Deng; Kenny Ye; Christopher Su; Janaki Sharma; Yuanquan Yang; Balazs Halmos; Roman Perez-Soler
Journal: Clin Lung Cancer Date: 2019-07-17 Impact factor: 4.785

3. Cost-effectiveness analysis of the addition of bevacizumab to chemotherapy as induction and maintenance therapy for metastatic non-squamous non-small-cell lung cancer.

Authors: H Zheng; L Xie; M Zhan; F Wen; T Xu; Q Li
Journal: Clin Transl Oncol Date: 2017-08-07 Impact factor: 3.405

4. Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib.

Authors: You-Cai Zhu; Wen-Xian Wang; Chun-Wei Xu; Qing-He Tan; Jian-Ying Li; Wu Zhuang; Zheng-Bo Song; Kai-Qi Du; Gang Chen; Tang-Feng Lv; Yong Song
Journal: J Thorac Dis Date: 2018-05 Impact factor: 2.895

5. Serum peptide expression and treatment responses in patients with advanced non-small-cell lung cancer.

Authors: Juan An; Chuan-Hao Tang; Na Wang; Yi Liu; Jin Lv; Bin Xu; Xiao-Yan Li; Wan-Feng Guo; Hong-Jun Gao; Kun He; Xiao-Qing Liu
Journal: Oncol Lett Date: 2018-04-11 Impact factor: 2.967

6. Incorporating personalized gene sequence variants, molecular genetics knowledge, and health knowledge into an EHR prototype based on the Continuity of Care Record standard.

Authors: Xia Jing; Stephen Kay; Thomas Marley; Nicholas R Hardiker; James J Cimino
Journal: J Biomed Inform Date: 2011-09-17 Impact factor: 6.317

7. Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study.

Authors: Lin Yang; Lei Shi; Qiang Fu; Huihua Xiong; Mengxian Zhang; Shiying Yu
Journal: Oncol Lett Date: 2012-01-31 Impact factor: 2.967

8. Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.

Authors: Hua-Li Liu; Guang Han; Min Peng; Yi-Ming Weng; Jing-Ping Yuan; Gui-Fang Yang; Jin-Ming Yu; Qi-Bin Song
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2017-12-21

9. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.

Authors: Yan Liu; Bing-Quan Wu; Hao-Hao Zhong; Pei Hui; Wei-Gang Fang
Journal: Int J Clin Exp Pathol Date: 2013-08-15

10. EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.

Authors: Maria I Toki; Daniel E Carvajal-Hausdorf; Mehmet Altan; Joseph McLaughlin; Brian Henick; Kurt A Schalper; Konstantinos N Syrigos; David L Rimm
Journal: J Thorac Oncol Date: 2016-07-20 Impact factor: 15.609